Anti-fibrotic therapies target TGF-beta pathways and myofibroblast activity

https://www.4shared.com/office/8oMZcnkKge/pdf-90872-48901.html

Anti-fibrotic therapies target TGF-beta pathways and myofibroblast activity, preserving organ function during regeneration and limiting pathological remodeling.